MXCT – maxcyte, inc. (US:NASDAQ)
Stock Stats
News
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MaxCyte (MXCT) was upgraded by Wall Street Zen from "sell" to "hold".
MaxCyte (MXCT) had its price target lowered by Craig Hallum from $7.00 to $5.00. They now have a "buy" rating on the stock.
MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook [Seeking Alpha]
Form 4 MAXCYTE, INC. For: Mar 27 Filed by: Masoud Maher
Form 8-K MAXCYTE, INC. For: Mar 23
Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: VANGUARD GROUP INC
Form 10-K MAXCYTE, INC. For: Dec 31
Form 8-K MAXCYTE, INC. For: Mar 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.